| Financial Year |
March 31 2023 |
| Monetary Funds |
1,401,944,312.18 |
| Held-for-trading Financial Assets |
247,112,165.85 |
| Notes Receivable |
4,749,437.75 |
| Accounts Receivable |
773,873,898.55 |
| Advances to Suppliers |
3,487,597.98 |
| Other Receivables |
57,599,678.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,274,590.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,857,904.71 |
| Total Current Assets |
2,517,899,585.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,808,244.46 |
| Investment Properties |
40,658,293.41 |
| Fixed Assetes |
403,104,749.01 |
| Under-construction Projects |
217,810,919.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
215,586,057.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,097,290.62 |
| Deferred Income Tax Assets |
27,170,508.99 |
| Other Non-Current Assets |
36,256,432.34 |
| Sub-Total of Non-Current Assets |
1,290,312,732.07 |
| Total Assets |
3,808,212,317.76 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,875,120.73 |
| Accounts Payable |
510,138,360.16 |
| Accounts Received In Advance |
3,851,038.71 |
| Employee Compensation Payable |
42,312,012.04 |
| Taxes Payable |
53,059,046.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,828,461.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
109,566,053.56 |
| Other Current Liabilities |
63,661.47 |
| Sub-Total of Current Liabilities |
758,815,803.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,851,192.43 |
| Deferred Income Tax Liabilities |
25,029,209.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
241,190,770.50 |
| Total Liabilities |
1,000,006,573.52 |
| Paid-In Capital(Or Share Stock) |
230,601,779.00 |
| Capital Surplus |
1,310,920,081.05 |
| Surplus Reserve |
37,834,457.80 |
| LESS:Treasury Stock |
50,055,203.74 |
| Undistributed Profits |
1,156,164,554.73 |
| Minority Stockholder's Interest |
109,354,998.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,698,850,746.17 |
| Owner's Equity（Stockholder's Equity） |
2,808,205,744.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,808,212,317.76 |
